SCWorx Receives Nasdaq Hearings Panel Decision Granting the Company’s Request to Continue its Listing on the Nasdaq Stock Market, Subject to Compliance Conditions
Summary
SCWorx received Nasdaq Hearings Panel approval to remain listed, but only if it meets a set of compliance deadlines. The company must secure shareholder approval for a reverse split, execute the split, and then trade at or above $1.00 for 20 straight sessions. If it misses those deadlines, Nasdaq will delist the stock and trading will remain on OTC Markets. SCWorx says it will keep working on its healthcare supply chain data platform and customer and partner relationships while it completes the compliance plan.
Classifications
industries
HealthTech
applications
Data Management
AskAI Classifications
Labels
Healthcare Software
Supply Chain Management Software
Data Management Software
Linked Companies
SCWorx
$1M to $5M